Welcome to our dedicated page for Tian Ruixiang Hldgs news (Ticker: TIRX), a resource for investors and traders seeking the latest updates and insights on Tian Ruixiang Hldgs stock.
TIAN RUIXIANG Holdings Ltd (NASDAQ: TIRX) is a Beijing-headquartered insurance broker that operates in China through a variable interest entity and distributes property, casualty, health, life, and other insurance products. The TIRX news feed highlights company announcements, strategic transactions, financial updates, and regulatory disclosures that shape the outlook for this insurance brokerage and its related businesses.
Investors and observers can use this page to follow TIAN RUIXIANG’s corporate developments, including its expansion into AI-enabled health insurance risk management through the acquisition of Ucare Inc., described as the operator of a cloud-based AI-driven hospital and health insurance risk management platform in China. News items also cover the company’s moves to diversify and globalize its operations via share exchange agreements to acquire BEYOND COASTLINE HOLDINGS LIMITED, a Southeast Asian new retail group focused on beauty and wellness holdings operations, and REN Talents Inc., a U.S.-based talent management and agency business described as a full-service creative brand agency.
The TIRX news stream includes capital markets and governance updates such as the pricing of registered direct offerings of Class A ordinary shares and warrants, the implementation of a five-to-one reverse stock split and related shareholder approvals, changes in the company’s independent auditor, and leadership transitions at the board and chief executive level. It also features financial reporting news, including half-year and full-year results, commentary on revenue trends in insurance commissions, and information on compliance with Nasdaq’s periodic filing requirements.
By reviewing the latest TIRX news, readers can track how TIAN RUIXIANG’s insurance brokerage activities, AI-driven health insurance initiatives, and acquisitions in new retail and branding are reflected in its public communications and regulatory announcements. This page can be revisited to see new press releases and Form 6-K summaries as they are issued.
TIAN RUIXIANG Holdings Ltd (TIRX) announced plans to enter the healthcare management industry in China. The Company aims to collaborate with various sectors, including governments and pharmaceutical companies, to cater to high-net-worth families and address the needs of the aging population. Chairman Zhe Wang emphasized that this move aligns with favorable government policies and increasing healthcare demands, particularly in anti-cancer and elderly care management. This strategy is expected to provide long-term value to shareholders amidst a growing market.
TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) announced a strategic cooperation agreement with the Anqing Road Transport Administrative Center on June 15, 2021. This partnership aims to provide risk management services to enhance safety and operational efficiency in Anqing city, which has around 824,000 vehicles and 1.24 million drivers. Zhe Wang, CEO of TIRX, emphasized the mutual benefits of this collaboration, stating a commitment to seek further opportunities with government entities for customized solutions in risk management.
Tian Ruixiang Holdings Ltd (Nasdaq: TIRX) announced the initial closing of a follow-on public offering, raising US$15 million from the sale of 2,000,000 units at US$7.50 per unit. Each unit includes one Class A ordinary share and one warrant priced at US$8.00. The company plans to offer up to a total of 4,800,000 units before the offering's termination on July 17, 2021. Proceeds will be utilized for developing an information data platform, customer service systems, and R&D.
TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) has announced a follow-on public offering of up to 4.8 million units priced at US$7.50 each. Each unit includes one Class A ordinary share and one warrant to purchase a Class A ordinary share at US$8.00. The offering, expected to close around June 7, 2021, is projected to generate gross proceeds of US$15 million initially, with a potential total of US$36 million. Proceeds will fund an information data platform, customer service system, and product R&D.
TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) announced its collaboration with Zhongkang Yiyang Health Technology Co., Ltd to launch the "Zhongkang Huimin Cancer Prevention Insurance". This specialty health insurance product will target cancer prevention and treatment for residents in Mainland China and will be underwritten by a major Chinese insurance firm. The initiative is part of the "China Cancer Prevention Public Welfare Project" organized by the China Anti-Aging Promotion Association.
TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) announced on April 29, 2021, that it has regained compliance with Nasdaq Listing Rule 5250(c)(1), following the timely filing of its Annual Report on Form 20-F for the fiscal year ended October 31, 2020. The notice from Nasdaq was received subsequent to the filing, confirming the company's adherence to reporting requirements. TIAN RUIXIANG Holdings Ltd operates as an insurance broker in China, offering property, casualty, and life insurance products.
TIAN RUIXIANG Holdings Ltd (TIRX) reported a 62.3% revenue growth for fiscal year 2020, totaling $3.25 million, driven by an increase in sales professionals and marketing efforts. Operating expenses rose 41.6% to $2.69 million, with a notable increase in selling and marketing costs. The company achieved a net income of $634,000, a 260.7% increase year-over-year, resulting in an earnings per share of $0.13. Despite challenges from COVID-19, TIRX expects continued recovery and growth in the Chinese economy, supporting further business development.
TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) announced that it received a notice from Nasdaq on April 21, 2021, for failing to timely file its Annual Report on Form 20-F for the fiscal year ended October 31, 2020. This failure puts the Company out of compliance with Nasdaq Listing Rule 5250(c)(1), but there will be no immediate impact on its security listing. The Company must submit a compliance plan by May 5, 2021, to potentially regain compliance by August 27, 2021. TIAN RUIXIANG is known for distributing various insurance products in China.
TIAN RUIXIANG Holdings Ltd announced the successful closing of its initial public offering (IPO) of 3,000,000 Class A ordinary shares at $4 per share, raising $12 million before expenses. The shares began trading on the Nasdaq under the symbol 'TIRX' on January 27, 2021. Proceeds will fund new branches, investments in an Internet insurance center, and general working capital. Additionally, underwriters have a 45-day option to purchase 450,000 more shares. The IPO registration was effective as of January 26, 2021.
TIAN RUIXIANG Holdings Ltd announced the pricing of its initial public offering of up to 3,000,000 Class A ordinary shares at $4 per share, aiming for gross proceeds of $12 million. The shares will trade on Nasdaq under the ticker symbol TIRX, with trading commencing on January 27, 2021. The proceeds will fund new branch openings, research and development for an Internet insurance center, and general working capital. The offering is underwritten by Network 1 Financial Securities, with an option for underwriters to purchase an additional 450,000 shares.